---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-017164"
form_type: "8-K"
ticker: "ACHV"
cik: "0000949858"
company_name: "ACHIEVE LIFE SCIENCES, INC."
filed_at: "2023-05-03T23:59:59+00:00"
generated_at: "2026-06-16T02:22:49.653725+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Achieve Life Sciences updates principal executive offices to two locations effective April 28, 2023

## Summary
- Effective April 28, 2023, Achieve Life Sciences established principal executive offices at 1040 West Georgia, Suite 1030, Vancouver, BC, Canada V6E 4H1.
- Also effective April 28, 2023, the Company's principal executive offices include 22722 29th Drive SE, Suite 100, Bothell, WA 98021.
- The address change was disclosed under Item 7.01 Regulation FD Disclosure in an 8-K filed May 3, 2023.

## SEC filing metadata
- accession: 0000950170-23-017164
- form_type: 8-K
- ticker: ACHV
- cik: 0000949858
- company_name: ACHIEVE LIFE SCIENCES, INC.
- filed_at: 2023-05-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/949858/000095017023017164/0000950170-23-017164-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/949858/000095017023017164/achv-20230428.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-017164
- JSON: https://secwatch.observer/filing/0000950170-23-017164.json
- Plain text: https://secwatch.observer/filing/0000950170-23-017164.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.